SCHEMBL18985175

SCHEMBL18985175

Cc1cc(OC(=O)c2ccc(OCCCCCCO[Si](C(C)C)(C(C)C)C(C)C)cc2)ccc1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
MRGPRX4 Q96LA9 5/20 0.41
HIF1A Q16665 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
RAB9A P51151 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
NPC1 O15118 2/20 0.40
MAPK1 P28482 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29783189 1.00 PPARG (0.42) PPARGPPARDPPARAFFAR4MRGPRX4
SCHEMBL18985152 0.86 FFAR4 (0.46) PPARGPPARDFFAR4MRGPRX4HIF1A
SCHEMBL29783373 0.86 FFAR4 (0.46) PPARGPPARDFFAR4MRGPRX4HIF1A
SCHEMBL18985165 0.82 LMNA (0.46) SMN1; SMN2KMT2AL3MBTL1NPC1NFKB1
SCHEMBL7713567 0.81 FFAR4 (0.56) PPARGPPARDFFAR4MRGPRX4HIF1A
SCHEMBL18985174 0.80 KDM4E (0.41) SMN1; SMN2KMT2ANPC1NFKB1NFKB2
SCHEMBL18985161 0.77 KDM4E (0.39) SMN1; SMN2KMT2ANPC1NFKB1NFKB2
SCHEMBL22435487 0.75 LMNA (0.48) PPARGPPARDPPARASMN1; SMN2KMT2A
SCHEMBL23824146 0.73 FFAR4 (0.48) PPARGPPARDFFAR4MRGPRX4SMN1; SMN2
SCHEMBL19027823 0.73 MAPT (0.62) SMN1; SMN2RAB9AKMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108368425-B Liquid crystal mixture and liquid crystal display 默克专利股份有限公司(DE) 2023-01-13 CN disclosed
CN-114702965-A Liquid crystal mixture and liquid crystal display 默克专利股份有限公司 2022-07-05 CN disclosed
US-20220106525-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2022-04-07 US disclosed
EP-3864111-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2021-08-18 EP disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
US-11053442-B2 Liquid crystal mixture and liquid crystal display MERCK PATENT GMBH (DE) 2021-07-06 US disclosed
CN-112805353-A Liquid crystal mixture and liquid crystal display 默克专利股份有限公司 2021-05-14 CN disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
US-20200255740-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-08-13 US disclosed
EP-3390570-B1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2020-03-18 EP disclosed
EP-3390570-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2018-10-24 EP disclosed
WO-2017102068-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed
WO-2017102068-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106525-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY CXCR1, PYM1, F11 PPARG 4332/4885PPARD 4026/4885PPARA 4063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.